Form 144 IRULYA THERAPEUTICS INC For: 21 October
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IRulya Therapeutics Inc (IRLA)
Track today's live IRulya (IRLA) share price, performance and key data on this page with our current NASDAQ:IRLA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the IRulya share price on the NASDAQ exchange. Use the dropdown to switch exchange for the IRLA share price, head to our technical summary section, which provides analysis on IRulya share price buy/sell indicators using real-time data (or discuss the IRulya (IRLA) stock price today with other investors in the IRulya NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:IRLA share price (ISIN: US22053A3059) to enhance your trading decisions with our free investment tools and resources.
What Is the IRulya Therapeutics Inc Share Price Today?
The IRulya share price today is 29.310.
What Is the Stock Symbol for IRulya Therapeutics Inc
The stock symbol (or 'ticker') for IRulya Therapeutics Inc is "IRLA."
What Stock Exchange Does IRulya Therapeutics Inc Trade On?
IRulya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is IRulya Therapeutics Inc a Good Stock to Buy?
Determining whether IRulya (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:IRLA share price (ISIN: US22053A3059) to enhance your trading decisions with our free investment tools and resources.
What Is the IRulya Therapeutics Inc Share Price Today?
The IRulya share price today is 29.310.
What Is the Stock Symbol for IRulya Therapeutics Inc
The stock symbol (or 'ticker') for IRulya Therapeutics Inc is "IRLA."
What Stock Exchange Does IRulya Therapeutics Inc Trade On?
IRulya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is IRulya Therapeutics Inc a Good Stock to Buy?
Determining whether IRulya (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.030
30.910
52 wk Range
3.660
909.980
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.03030.910
52 wk Range
3.660909.980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRLA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
75.000
Upside
+155.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 75.000
(+155.89% Upside)
Earnings
Latest Release
14/08/2026
EPS / Forecast
-12.31 / -9.40
Revenue / Forecast
-- / --
Compare IRLA to Peers and Sector
Metrics to compare | IRLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRLAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −1.6x | −0.2x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | −0.9x | 1.6x | 2.6x | |
Price / LTM Sales | - | 3.1x | 2.8x | |
Upside (Analyst Target) | 155.9% | 361.9% | 62.7% | |
Fair Value Upside | Unlock | 16.6% | 8.0% | Unlock |
IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidate comprises eDSP, which is in Phase 3 for the treatment of rare pediatric neurodegenerative diseases, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in the ATM gene. Its AIDE technology platform is a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells and consists of automated equipment, the RCL, a sterile single-use consumable treatment kit comprising medical device kits, syringe kits, and process solutions. IRulya Therapeutics Inc. was formerly known as Quince Therapeutics, Inc. and changed its name to IRulya Therapeutics Inc. in October 2026. The company was incorporated in 2012 and is headquartered in New Haven, Connecticut.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the IRulya (NASDAQ: IRLA) Share Price Today?
The IRulya stock price today is 29.310 USD.
What Stock Exchange Does IRulya (IRLA) Trade On?
IRulya is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for IRulya?
The stock symbol (also called a 'ticker') for IRulya is "IRLA."
What Is the Current IRulya Market Capitalisation?
As of today, IRulya (NASDAQ: IRLA) market cap is 31.440M USD.
What Is IRulya's (IRLA) Earnings Per Share (TTM)?
The IRulya EPS is currently -51.81 (Trailing Twelve Months).
When Is the Next IRulya Earnings Date?
IRulya's next earnings report will be released on 18/11/2026.
Is IRLA a Buy or Sell From a Technical Analyst Perspective?
Based on today's IRulya moving averages and other technical indicators, the daily buy/sell signal for IRLA stock is Strong Sell.
How Many Times Has IRulya Stock Split?
IRulya has split 2 times. (See the IRLA stock split history page for full effective split date and price information.)
How Many Employees Does IRulya Have?
IRulya has 38 employees, based on their latest Companies House report.
What is the current trading status of IRulya (NASDAQ: IRLA)?
As of 05/11/2026, IRulya (IRLA) is trading at a share price of 29.310 USD, with a previous close of 31.670 USD. The stock has fluctuated within a day range of 27.030 USD to 30.910 USD, while its 52-week range spans from 3.660 USD to 909.980 USD.
What Is IRulya (IRLA) Price Target According to Analysts?
The average 12-month price target for IRulya is 75.000 USD, with a high estimate of 98 USD and a low estimate of 65 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +155.89% Upside potential.
What Is the IRLA Premarket Price?
IRLA's last pre-market stock price is 31.000 USD. The pre-market share volume is 10.000, and the stock has decreased by -0.670, or -2.120%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.